Biostar Pharmaceuticals, Inc. (OTC:BSPM) has announced that it will launch its Xin Aoxing Oleanolic Acid Capsules in Beijing and Shanghai in January 2010. The capsules will be sold to treat Hepatitis B. The company expects to earn $9 million in incremental revenues during 2010 from the new markets with average gross margins of 72%.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
Biostar Pharmaceuticals develops, manufactures, and markets pharmaceutical and medical nutrient products. It’s most popular product is the Xin Aoxing Oleanolic Acid Capsule for chronic hepatitis B. Hepatitis B currently affects 10% of the Chinese population.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
